ID   G6PE_MOUSE              Reviewed;         789 AA.
AC   Q8CFX1; A2A7A9; B2KGW7; Q8BLH1;
DT   30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 137.
DE   RecName: Full=GDH/6PGL endoplasmic bifunctional protein {ECO:0000305|PubMed:12831846};
DE   Includes:
DE     RecName: Full=Hexose-6-phosphate dehydrogenase {ECO:0000303|PubMed:4169027};
DE     AltName: Full=Glucose 1-dehydrogenase {ECO:0000305|PubMed:4169027};
DE              EC=1.1.1.47 {ECO:0000269|PubMed:4169027};
DE     AltName: Full=Glucose-6-phosphate dehydrogenase {ECO:0000305|PubMed:4169027};
DE              EC=1.1.1.363 {ECO:0000269|PubMed:12831846, ECO:0000269|PubMed:4169027};
DE   Includes:
DE     RecName: Full=6-phosphogluconolactonase {ECO:0000303|PubMed:12831846};
DE              Short=6PGL {ECO:0000303|PubMed:12831846};
DE              EC=3.1.1.31 {ECO:0000269|PubMed:12831846};
DE   Flags: Precursor;
GN   Name=H6pd {ECO:0000312|MGI:MGI:2140356};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE
RP   SPECIFICITY, PATHWAY, AND TISSUE SPECIFICITY.
RX   PubMed=4169027; DOI=10.1016/s0021-9258(18)99426-3;
RA   Beutler E., Morrison M.;
RT   "Localization and characteristics of hexose 6-phosphate dehydrogenase
RT   (glucose dehydrogenase).";
RL   J. Biol. Chem. 242:5289-5293(1967).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, PATHWAY, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=12831846; DOI=10.1016/s0003-9861(03)00229-7;
RA   Clarke J.L., Mason P.J.;
RT   "Murine hexose-6-phosphate dehydrogenase: a bifunctional enzyme with broad
RT   substrate specificity and 6-phosphogluconolactonase activity.";
RL   Arch. Biochem. Biophys. 415:229-234(2003).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16356929; DOI=10.1074/jbc.m512635200;
RA   Lavery G.G., Walker E.A., Draper N., Jeyasuria P., Marcos J.,
RA   Shackleton C.H., Parker K.L., White P.C., Stewart P.M.;
RT   "Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-
RT   hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation.";
RL   J. Biol. Chem. 281:6546-6551(2006).
RN   [7]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17656460; DOI=10.1210/en.2007-0593;
RA   Rogoff D., Ryder J.W., Black K., Yan Z., Burgess S.C., McMillan D.R.,
RA   White P.C.;
RT   "Abnormalities of glucose homeostasis and the hypothalamic-pituitary-
RT   adrenal axis in mice lacking hexose-6-phosphate dehydrogenase.";
RL   Endocrinology 148:5072-5080(2007).
RN   [8]
RP   TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=18218694; DOI=10.1210/en.2007-1705;
RA   Bujalska I.J., Hewitt K.N., Hauton D., Lavery G.G., Tomlinson J.W.,
RA   Walker E.A., Stewart P.M.;
RT   "Lack of hexose-6-phosphate dehydrogenase impairs lipid mobilization from
RT   mouse adipose tissue.";
RL   Endocrinology 149:2584-2591(2008).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=18222920; DOI=10.1074/jbc.m710067200;
RA   Lavery G.G., Walker E.A., Turan N., Rogoff D., Ryder J.W., Shelton J.M.,
RA   Richardson J.A., Falciani F., White P.C., Stewart P.M., Parker K.L.,
RA   McMillan D.R.;
RT   "Deletion of hexose-6-phosphate dehydrogenase activates the unfolded
RT   protein response pathway and induces skeletal myopathy.";
RL   J. Biol. Chem. 283:8453-8461(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [11]
RP   SUCCINYLATION [LARGE SCALE ANALYSIS] AT LYS-205 AND LYS-424, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
CC   -!- FUNCTION: Bifunctional enzyme localized in the lumen of the endoplasmic
CC       reticulum that catalyzes the first two steps of the oxidative branch of
CC       the pentose phosphate pathway/shunt, an alternative to glycolysis and a
CC       major source of reducing power and metabolic intermediates for
CC       biosynthetic processes (PubMed:4169027, PubMed:12831846,
CC       PubMed:16356929, PubMed:18222920). Has a hexose-6-phosphate
CC       dehydrogenase activity, with broad substrate specificity compared to
CC       glucose-6-phosphate 1-dehydrogenase/G6PD, and catalyzes the first step
CC       of the pentose phosphate pathway (PubMed:4169027, PubMed:12831846,
CC       PubMed:18222920). In addition, acts as a 6-phosphogluconolactonase and
CC       catalyzes the second step of the pentose phosphate pathway
CC       (PubMed:12831846). May have a dehydrogenase activity for alternative
CC       substrates including glucosamine 6-phosphate and glucose 6-sulfate
CC       (PubMed:12831846). The main function of this enzyme is to provide
CC       reducing equivalents such as NADPH to maintain the adequate levels of
CC       reductive cofactors in the oxidizing environment of the endoplasmic
CC       reticulum (PubMed:12831846, PubMed:16356929, PubMed:17656460,
CC       PubMed:18222920). By producing NADPH that is needed by reductases of
CC       the lumen of the endoplasmic reticulum like corticosteroid 11-beta-
CC       dehydrogenase isozyme 1/HSD11B1, indirectly regulates their activity
CC       (PubMed:16356929). {ECO:0000269|PubMed:12831846,
CC       ECO:0000269|PubMed:16356929, ECO:0000269|PubMed:17656460,
CC       ECO:0000269|PubMed:18222920, ECO:0000269|PubMed:4169027}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glucose 6-phosphate + NAD(+) = 6-phospho-D-glucono-1,5-
CC         lactone + H(+) + NADH; Xref=Rhea:RHEA:38215, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:57955,
CC         ChEBI:CHEBI:61548; EC=1.1.1.363;
CC         Evidence={ECO:0000269|PubMed:4169027};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38216;
CC         Evidence={ECO:0000305|PubMed:4169027};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glucose 6-phosphate + NADP(+) = 6-phospho-D-glucono-1,5-
CC         lactone + H(+) + NADPH; Xref=Rhea:RHEA:15841, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:57955, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:61548; EC=1.1.1.363;
CC         Evidence={ECO:0000269|PubMed:12831846, ECO:0000269|PubMed:4169027};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15842;
CC         Evidence={ECO:0000305|PubMed:4169027};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=6-phospho-D-glucono-1,5-lactone + H2O = 6-phospho-D-gluconate
CC         + H(+); Xref=Rhea:RHEA:12556, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57955, ChEBI:CHEBI:58759; EC=3.1.1.31;
CC         Evidence={ECO:0000269|PubMed:12831846};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12557;
CC         Evidence={ECO:0000305|PubMed:12831846};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-deoxy-D-glucose 6-phosphate + NAD(+) = 2-deoxy-6-phospho-D-
CC         glucono-1,5-lactone + H(+) + NADH; Xref=Rhea:RHEA:62064,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:84760, ChEBI:CHEBI:145420;
CC         Evidence={ECO:0000269|PubMed:4169027};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62065;
CC         Evidence={ECO:0000305|PubMed:4169027};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-deoxy-D-glucose 6-phosphate + NADP(+) = 2-deoxy-6-phospho-D-
CC         glucono-1,5-lactone + H(+) + NADPH; Xref=Rhea:RHEA:62068,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:84760, ChEBI:CHEBI:145420;
CC         Evidence={ECO:0000269|PubMed:12831846, ECO:0000269|PubMed:18222920,
CC         ECO:0000269|PubMed:4169027};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62069;
CC         Evidence={ECO:0000305|PubMed:4169027};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-galactose 6-phosphate + NADP(+) = 6-phospho-D-galactono-1,5-
CC         lactone + H(+) + NADPH; Xref=Rhea:RHEA:62072, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:91004,
CC         ChEBI:CHEBI:145419; Evidence={ECO:0000269|PubMed:12831846,
CC         ECO:0000269|PubMed:4169027};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62073;
CC         Evidence={ECO:0000305|PubMed:4169027};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-galactose 6-phosphate + NAD(+) = 6-phospho-D-galactono-1,5-
CC         lactone + H(+) + NADH; Xref=Rhea:RHEA:62076, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:91004,
CC         ChEBI:CHEBI:145419; Evidence={ECO:0000269|PubMed:4169027};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62077;
CC         Evidence={ECO:0000305|PubMed:4169027};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glucosamine 6-phosphate + NADP(+) = 2-amino-2-deoxy-6-
CC         phospho-D-glucono-1,5-lactone + 2 H(+) + NADPH; Xref=Rhea:RHEA:62088,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:58725, ChEBI:CHEBI:145423;
CC         Evidence={ECO:0000269|PubMed:12831846};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62089;
CC         Evidence={ECO:0000305|PubMed:12831846};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glucose + NAD(+) = D-glucono-1,5-lactone + H(+) + NADH;
CC         Xref=Rhea:RHEA:14293, ChEBI:CHEBI:4167, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16217, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.47;
CC         Evidence={ECO:0000269|PubMed:4169027};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14294;
CC         Evidence={ECO:0000305|PubMed:4169027};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glucose + NADP(+) = D-glucono-1,5-lactone + H(+) + NADPH;
CC         Xref=Rhea:RHEA:14405, ChEBI:CHEBI:4167, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16217, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.47;
CC         Evidence={ECO:0000269|PubMed:4169027};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14406;
CC         Evidence={ECO:0000305|PubMed:4169027};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-glucose 6-sulfate + NADP(+) = 6-sulfo-D-glucono-1,5-lactone
CC         + H(+) + NADPH; Xref=Rhea:RHEA:62080, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:145424,
CC         ChEBI:CHEBI:145427; Evidence={ECO:0000269|PubMed:12831846};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62081;
CC         Evidence={ECO:0000305|PubMed:12831846};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4065 mM for D-glucose (at pH 7.1 in the presence of NADP)
CC         {ECO:0000269|PubMed:4169027};
CC         KM=725 mM for D-glucose (at pH 7.1 in the presence of NAD)
CC         {ECO:0000269|PubMed:4169027};
CC         KM=532 mM for D-glucose (at pH 9.6 in the presence of NAD)
CC         {ECO:0000269|PubMed:4169027};
CC         KM=120 uM for D-glucose 6-phosphate (at pH 9.6 in the presence of
CC         NADP) {ECO:0000269|PubMed:4169027};
CC         KM=28 uM for D-glucose 6-phosphate (at pH 9.6 in the presence of NAD)
CC         {ECO:0000269|PubMed:4169027};
CC         KM=66 uM for 2-deoxy-D-glucose 6-phosphate (at pH 7.1 in the presence
CC         of NADP) {ECO:0000269|PubMed:4169027};
CC         KM=12 uM for 2-deoxy-D-glucose 6-phosphate (at pH 7.1 in the presence
CC         of NAD) {ECO:0000269|PubMed:4169027};
CC         KM=5.89 mM for 2-deoxy-D-glucose 6-phosphate (at pH 9.6 in the
CC         presence of NADP) {ECO:0000269|PubMed:4169027};
CC         KM=4.35 mM for 2-deoxy-D-glucose 6-phosphate (at pH 9.6 in the
CC         presence of NAD) {ECO:0000269|PubMed:4169027};
CC         KM=7 uM for D-galactopyranose 6-phosphate (at pH 7.1 in the presence
CC         of NADP) {ECO:0000269|PubMed:4169027};
CC         KM=504 uM for D-galactopyranose 6-phosphate (at pH 9.6 in the
CC         presence of NADP) {ECO:0000269|PubMed:4169027};
CC         KM=223 uM for D-galactopyranose 6-phosphate (at pH 7.1 in the
CC         presence of NAD) {ECO:0000269|PubMed:4169027};
CC         KM=9 uM for NADP (at pH 7.1 in the presence of galactose 6-phosphate)
CC         {ECO:0000269|PubMed:4169027};
CC         KM=14 uM for NADP (at pH 9.6 in the presence of galactose
CC         6-phosphate) {ECO:0000269|PubMed:4169027};
CC         KM=4 uM for NADP (at pH 9.6 in the presence of D-glucose 6-phosphate)
CC         {ECO:0000269|PubMed:4169027};
CC         KM=12 uM for NADP (at pH 7.1 in the presence of D-glucose)
CC         {ECO:0000269|PubMed:4169027};
CC         KM=52 uM for NAD (at pH 7.1 in the presence of D-glucose)
CC         {ECO:0000269|PubMed:4169027};
CC         KM=47 uM for NADP (at pH 9.6 in the presence of D-glucose)
CC         {ECO:0000269|PubMed:4169027};
CC         KM=261 uM for NAD (at pH 9.6 in the presence of D-glucose)
CC         {ECO:0000269|PubMed:4169027};
CC         KM=34 uM for NAD (at pH 7.1 in the presence of D-glucose)
CC         {ECO:0000269|PubMed:4169027};
CC         KM=72 uM for NAD (at pH 9.6 in the presence of D-glucose)
CC         {ECO:0000269|PubMed:4169027};
CC       pH dependence:
CC         Optimum pH is 6.0-8.0. {ECO:0000269|PubMed:12831846};
CC   -!- PATHWAY: Carbohydrate degradation; pentose phosphate pathway; D-
CC       ribulose 5-phosphate from D-glucose 6-phosphate (oxidative stage).
CC       {ECO:0000269|PubMed:12831846, ECO:0000269|PubMed:4169027}.
CC   -!- PATHWAY: Carbohydrate degradation; pentose phosphate pathway; D-
CC       ribulose 5-phosphate from D-glucose 6-phosphate (oxidative stage): step
CC       2/3. {ECO:0000269|PubMed:12831846}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:12831846}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000305|PubMed:12831846}.
CC   -!- TISSUE SPECIFICITY: Expressed in liver (at protein level)
CC       (PubMed:4169027). Expressed in muscles (PubMed:18222920). Expressed in
CC       adipose tissues (PubMed:18218694). {ECO:0000269|PubMed:18218694,
CC       ECO:0000269|PubMed:18222920, ECO:0000269|PubMed:4169027}.
CC   -!- DISRUPTION PHENOTYPE: Mice lacking H6pd are born at the expected
CC       Mendelian frequency and do not show overt phenotype (PubMed:16356929).
CC       However, they display cellular inability to convert 11-
CC       dehydrocorticosterone (11-DHC) to corticosterone and present increased
CC       corticosterone to 11-DHC conversion associated with adrenal hyperplasia
CC       (PubMed:16356929). Mutant mice also display fasting hypoglycemia and
CC       perturbed lipid mobilization that are probably due to the
CC       aforementioned effect on corticosterone metabolism and blunted
CC       intracellular action of the hormone (PubMed:17656460, PubMed:18218694).
CC       Skeletal myopathy associated with a dysregulation of the expression of
CC       proteins associated with calcium homeostasis in the sarcoplasmic
CC       reticulum and an activation of the unfolded protein response are also
CC       observed (PubMed:18222920). {ECO:0000269|PubMed:16356929,
CC       ECO:0000269|PubMed:17656460, ECO:0000269|PubMed:18218694,
CC       ECO:0000269|PubMed:18222920}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the glucose-6-
CC       phosphate dehydrogenase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the
CC       glucosamine/galactosamine-6-phosphate isomerase family. 6-
CC       phosphogluconolactonase subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC32260.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK045199; BAC32260.1; ALT_INIT; mRNA.
DR   EMBL; AK159373; BAE35029.1; -; mRNA.
DR   EMBL; AL606914; CAM16119.1; -; Genomic_DNA.
DR   EMBL; CU463327; CAQ51682.1; -; Genomic_DNA.
DR   EMBL; BC042677; AAH42677.1; -; mRNA.
DR   CCDS; CCDS71524.1; -.
DR   RefSeq; NP_001277933.1; NM_001291004.1.
DR   RefSeq; NP_775547.2; NM_173371.4.
DR   AlphaFoldDB; Q8CFX1; -.
DR   SMR; Q8CFX1; -.
DR   BioGRID; 221399; 2.
DR   STRING; 10090.ENSMUSP00000030830; -.
DR   GlyConnect; 2334; 2 N-Linked glycans (1 site).
DR   GlyGen; Q8CFX1; 3 sites, 2 N-linked glycans (1 site).
DR   iPTMnet; Q8CFX1; -.
DR   PhosphoSitePlus; Q8CFX1; -.
DR   SwissPalm; Q8CFX1; -.
DR   EPD; Q8CFX1; -.
DR   jPOST; Q8CFX1; -.
DR   MaxQB; Q8CFX1; -.
DR   PaxDb; Q8CFX1; -.
DR   PRIDE; Q8CFX1; -.
DR   ProteomicsDB; 271657; -.
DR   Antibodypedia; 1350; 318 antibodies from 28 providers.
DR   DNASU; 100198; -.
DR   Ensembl; ENSMUST00000084117; ENSMUSP00000081134; ENSMUSG00000028980.
DR   GeneID; 100198; -.
DR   KEGG; mmu:100198; -.
DR   UCSC; uc008vxh.2; mouse.
DR   CTD; 9563; -.
DR   MGI; MGI:2140356; H6pd.
DR   VEuPathDB; HostDB:ENSMUSG00000028980; -.
DR   eggNOG; KOG0563; Eukaryota.
DR   eggNOG; KOG3147; Eukaryota.
DR   GeneTree; ENSGT00530000063435; -.
DR   HOGENOM; CLU_018975_0_0_1; -.
DR   InParanoid; Q8CFX1; -.
DR   OMA; DLHIFGQ; -.
DR   OrthoDB; 383995at2759; -.
DR   SABIO-RK; Q8CFX1; -.
DR   UniPathway; UPA00115; UER00409.
DR   BioGRID-ORCS; 100198; 0 hits in 72 CRISPR screens.
DR   PRO; PR:Q8CFX1; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; Q8CFX1; protein.
DR   Bgee; ENSMUSG00000028980; Expressed in left lobe of liver and 191 other tissues.
DR   ExpressionAtlas; Q8CFX1; baseline and differential.
DR   Genevisible; Q8CFX1; MM.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; IMP:MGI.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; ISS:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:0005739; C:mitochondrion; ISO:MGI.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IMP:MGI.
DR   GO; GO:0017057; F:6-phosphogluconolactonase activity; IDA:MGI.
DR   GO; GO:0030246; F:carbohydrate binding; ISO:MGI.
DR   GO; GO:0047934; F:glucose 1-dehydrogenase (NAD+) activity; IEA:RHEA.
DR   GO; GO:0047935; F:glucose 1-dehydrogenase (NADP+) activity; IEA:RHEA.
DR   GO; GO:0047936; F:glucose 1-dehydrogenase [NAD(P)] activity; IEA:UniProtKB-EC.
DR   GO; GO:0004345; F:glucose-6-phosphate dehydrogenase activity; IDA:MGI.
DR   GO; GO:0050661; F:NADP binding; ISO:MGI.
DR   GO; GO:0005975; P:carbohydrate metabolic process; ISO:MGI.
DR   GO; GO:0006006; P:glucose metabolic process; IBA:GO_Central.
DR   GO; GO:0006739; P:NADP metabolic process; ISO:MGI.
DR   GO; GO:0006098; P:pentose-phosphate shunt; IDA:MGI.
DR   GO; GO:0009051; P:pentose-phosphate shunt, oxidative branch; ISS:UniProtKB.
DR   GO; GO:2000064; P:regulation of cortisol biosynthetic process; IMP:UniProtKB.
DR   CDD; cd01400; 6PGL; 1.
DR   InterPro; IPR005900; 6-phosphogluconolactonase_DevB.
DR   InterPro; IPR001282; G6P_DH.
DR   InterPro; IPR019796; G6P_DH_AS.
DR   InterPro; IPR022675; G6P_DH_C.
DR   InterPro; IPR022674; G6P_DH_NAD-bd.
DR   InterPro; IPR006148; Glc/Gal-6P_isomerase.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR037171; NagB/RpiA_transferase-like.
DR   PANTHER; PTHR23429; PTHR23429; 1.
DR   Pfam; PF02781; G6PD_C; 1.
DR   Pfam; PF00479; G6PD_N; 1.
DR   Pfam; PF01182; Glucosamine_iso; 1.
DR   PRINTS; PR00079; G6PDHDRGNASE.
DR   SUPFAM; SSF100950; SSF100950; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR01198; pgl; 1.
DR   PROSITE; PS00069; G6P_DEHYDROGENASE; 1.
PE   1: Evidence at protein level;
KW   Carbohydrate metabolism; Endoplasmic reticulum; Glucose metabolism;
KW   Glycoprotein; Hydrolase; Multifunctional enzyme; NAD; NADP; Oxidoreductase;
KW   Pyrrolidone carboxylic acid; Reference proteome; Signal.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000250|UniProtKB:P56201"
FT   CHAIN           17..789
FT                   /note="GDH/6PGL endoplasmic bifunctional protein"
FT                   /id="PRO_0000236794"
FT   REGION          17..524
FT                   /note="Hexose-6-phosphate dehydrogenase"
FT                   /evidence="ECO:0000305"
FT   REGION          525..538
FT                   /note="Linker"
FT                   /evidence="ECO:0000305"
FT   REGION          539..789
FT                   /note="6-phosphogluconolactonase"
FT                   /evidence="ECO:0000305"
FT   ACT_SITE        264
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P11411"
FT   BINDING         29..36
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P11413"
FT   BINDING         146
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P11413"
FT   BINDING         171
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P11413"
FT   BINDING         171
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P11413"
FT   BINDING         201..205
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P11413"
FT   BINDING         240
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P11413"
FT   BINDING         259
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P11413"
FT   BINDING         357
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P11413"
FT   BINDING         362
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P11413"
FT   MOD_RES         17
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000250|UniProtKB:P56201"
FT   MOD_RES         205
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         424
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   CARBOHYD        154
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        279
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        681
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        77
FT                   /note="V -> A (in Ref. 1; BAE35029, 2; CAQ51682 and 3;
FT                   AAH42677)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        106
FT                   /note="R -> H (in Ref. 1; BAE35029, 2; CAQ51682 and 3;
FT                   AAH42677)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        285
FT                   /note="A -> T (in Ref. 1; BAE35029, 2; CAQ51682 and 3;
FT                   AAH42677)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   789 AA;  88928 MW;  E970CE8B35D3E1E5 CRC64;
     MLLAAMCLAL LGCLQAQELK GHVSIILLGA TGDLAKKYLW QGLFQLYLDE AGKGHSFSFH
     GAALTAPQQG QKLMDKVLES LSCPKDLVPS RCDELKGQFL QLSQYRQLKT VEDYQTLNKD
     IETQVQQDGL WEAGRIFYFS VPPFAYADIA RNINSSCRPH PGAWLRVVFE KPFGHDHLSA
     QQLASELGSF FQEEEMYRVD HYLGKQAVAQ ILPFRDQNRK ALDGLWNRHH VERVEIILKE
     TIDAEGRASF YEEYGVIRDT LQNHLTEILT LVAMELPLNI SSSAAVLQHK LWAFQALRGL
     QKSSAILGQY QAYSGQVRRE LQKPDGFQSL TPTFAGVLVH IDNLRWEGVP FILMSGKALD
     ERVGYVRIVF KNRAYCTQSE RHWVPEQSRC LPQQIIFYIG HGELGHPAIL VSRNLFKPSL
     PTQKWKEVQD QPGLRLFGRP LSDYYAYRPV REQDAYSTLL SHIFHCRKES FITTENLLAS
     WVFWTPLLDS LAFEVPRPYP GGAENGQLLD FEFSGGQLTF SQQQLEVLIP DLGSVPKPSD
     FQVLGARYRQ SPLITAWPEE LISKLASDIE AAAVQAVRHF GKFHLALSGG SSPIALFQQL
     ATGHYSFPWA HTHLWLVDER CVPLSDPDSN FQGLQAHLLQ HVRVPYYNIH PMPVHLHQRL
     CAEEDQGAQT YASEISALVA NSSFDLVLLG MGTDGHTASL FPQSPTGLDG DQLVVLTESP
     FRPHQRMSLS LPLINRAKKV AVLVMGRTKR EITTLVSRVG HEPKKWPISG VVPLSGQLVW
     YMDYEAFLG
//
